In 2023, pancreatic cancer transitioned from being a rare form to a common cancer in Australia—a troublesome statistic, seeing as…
Clinical state oncology company Prescient Therapeutics (ASX: PTX) has received the US FDA’s Orphan Drug Designation for its PTX-100 drug,…
Offering some relief for people suffering from prostate cancer, Starpharma (ASX: SPL) might be on the verge of a breakthrough…
Since securing a European patent for their proprietary cancer vaccine HER-Vaxx, Imugene (ASX: IMU) have been busy. The Company has…
Sunbaking is a certified Australian pastime, so it comes as no surprise that we have the highest melanoma rate in…
Cancer treatment is slowly shifting away from the standard chemo and radiation and more towards immunotherapy as an alternative treatment.…